Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$276M |
| 2 |
IBM
IBM
|
+$272M |
| 3 |
Procter & Gamble
PG
|
+$161M |
| 4 |
Colgate-Palmolive
CL
|
+$151M |
| 5 |
BBBY
Bed Bath & Beyond Inc
BBBY
|
+$146M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verizon
VZ
|
+$405M |
| 2 |
CELG
Celgene Corp
CELG
|
+$207M |
| 3 |
Booking.com
BKNG
|
+$123M |
| 4 |
Eli Lilly
LLY
|
+$114M |
| 5 |
BEAM
BEAM INC COM STK (DE)
BEAM
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.85% |
| 2 | Healthcare | 13.92% |
| 3 | Consumer Discretionary | 12.37% |
| 4 | Industrials | 10.61% |
| 5 | Consumer Staples | 9.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
STL
1851
DELISTED
Sterling Bancorp
STL
| $1.58M | ﹤0.01% |
132,097
-51,600
| -28% | -$612K |
|
|
GNCMA
1852
DELISTED
GCI Liberty, Inc. Class A-1 Common Stock
GNCMA
| $1.58M | ﹤0.01% |
142,258
-63,707
| -31% | -$697K |
|
|
USAK
1853
DELISTED
USA Truck Inc
USAK
| $1.57M | ﹤0.01% |
84,700
-23,944
| -22% | -$412K |
|
1854
Cineverse
CNVS
$66.6M
| $1.57M | ﹤0.01% |
3,155
+434
| +16% | +$222K |
|
1855
Pebblebrook Hotel Trust
PEB
$2.07B
| $1.57M | ﹤0.01% |
42,500
-56,570
| -57% | -$1.99M |
|
1856
CarParts.com
PRTS
$49.4M
| $1.57M | ﹤0.01% |
43,410
+8,800
| +25% | +$289K |
|
|
ESIO
1857
DELISTED
Electro Scientific Industries
ESIO
| $1.56M | ﹤0.01% |
229,300
-18,500
| -7% | -$148K |
|
1858
Bristow Group
VTOL
$1.38B
| $1.56M | ﹤0.01% |
27,200
-19,393
| -42% | -$1.13M |
|
1859
AstroNova
ALOT
$226M
| $1.56M | ﹤0.01% |
114,750
+6,100
| +6% | +$79.8K |
|
1860
IRIDEX
IRIX
$14.7M
| $1.56M | ﹤0.01% |
187,600
+17,600
| +10% | +$151K |
|
|
PTVCB
1861
DELISTED
Protective Insurance Corporation Class B Common Stock
PTVCB
| $1.56M | ﹤0.01% |
60,100
-2,800
| -4% | -$72.6K |
|
1862
HCI Group
HCI
$2.3B
| $1.55M | ﹤0.01% |
+38,196
| New | +$1.48M |
|
1863
Rigel Pharmaceuticals
RIGL
$785M
| $1.53M | ﹤0.01% |
42,125
+21,072
| +100% | +$716K |
|
1864
Travelzoo
TZOO
$74.4M
| $1.53M | ﹤0.01% |
79,000
-90,600
| -53% | -$1.73M |
|
|
DWSN
1865
DELISTED
DAWSON GEOPHYSICAL CO
DWSN
| $1.53M | ﹤0.01% |
53,364
-15,992
| -23% | -$447K |
|
1866
Alpha and Omega Semiconductor
AOSL
$912M
| $1.52M | ﹤0.01% |
163,866
+65,462
| +67% | +$519K |
|
|
HPP
1867
Hudson Pacific Properties
HPP
$770M
| $1.51M | ﹤0.01% |
8,543
-7,257
| -46% | -$1.21M |
|
1868
BWX Technologies
BWXT
$15.9B
| $1.51M | ﹤0.01% |
65,147
-533,895
| -89% | -$12.7M |
|
|
INPH
1869
DELISTED
INTERPHASE CORP
INPH
| $1.51M | ﹤0.01% |
349,400
+800
| +0.2% | +$4.5K |
|
1870
Quantum Corp
QMCO
$1.06B
| $1.51M | ﹤0.01% |
7,748
+5,224
| +207% | +$954K |
|
|
SPPI
1871
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $1.51M | ﹤0.01% |
185,917
+14,610
| +9% | +$111K |
|
|
APAGF
1872
DELISTED
APCO OIL AND GAS INTERNATIONAL INC
APAGF
| $1.51M | ﹤0.01% |
104,800
+17,200
| +20% | +$248K |
|
1873
AngioDynamics
ANGO
$645M
| $1.5M | ﹤0.01% |
92,000
+24,454
| +36% | +$354K |
|
1874
West Bancorporation
WTBA
$507M
| $1.5M | ﹤0.01% |
98,465
+1,959
| +2% | +$28.8K |
|
|
CRZO
1875
DELISTED
Carrizo Oil & Gas Inc
CRZO
| $1.5M | ﹤0.01% |
21,652
-491,200
| -96% | -$28.5M |
|
Similar funds
Jim Simons's Q2 2014 Portfolio in Review
As of Q2 2014, Jim Simons held 3,246 positions worth $42.9B, up 2.9% from $41.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons's Q2 2014 filing shows 450 new, 1,273 increased, 1,008 reduced and 492 closed positions. Its largest new stake was Procter & Gamble: 2,001,729 shares worth $157M. The largest sale was Verizon, an estimated $405M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q2 2014 buy was Procter & Gamble: 2,001,729 shares worth $157M.
- Jim Simons added most to Pfizer in Q2 2014, an estimated $276M increase.
- Jim Simons's biggest Q2 2014 reduction was Verizon, cutting an estimated $405M.
- Jim Simons fully exited Booking.com in Q2 2014, selling an estimated $123M.
- Jim Simons's ten largest holdings make up 14% of its $42.9B portfolio in Q2 2014.
- Jim Simons opened 450 new positions and closed 492 in Q2 2014.
- Jim Simons's portfolio value rose 2.9% quarter-over-quarter to $42.9B.
Based on Renaissance Technologies's 13F filing for Q2 2014, filed 13 Aug 2014.